EISAI

Eisai is one of the world's leading research-based pharmaceutical companies. Eisai defines its corporate mission as "giving first thought to patients and their families, and to increasing the benefits health care provides." Eisai call this human health care (hhc). As part of our hhc mission we develop and deliver products that can contribute to the well-being of patients and their families whilst adhering to the highest legal and ethical standards in all that we do... Eisai's commitment to healthcare began in Japan in 1941. It was listed on the Tokyo/Osaka stock exchange in 1961 and began its global operations soon after. In the 1980's Eisai established operations in North America and Europe. Since that time it has grown rapidly to become a fully integrated pharmaceutical business, and is now one of the world's leading research-based pharmaceutical companies. In more recent years Eisai have expanded its operations into the Middle East and Africa. Eisai employs over 11,000 people..

Also known as: Eisai Pharma, Eisai Pharma AG, Eisai Switzerland

Registration numbers: CHE-112.380.282 (W)

Primary location: Zürich